Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$26,552,861
in 2 filings, $26.6M under 10b5-1 plans

Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-05-28 KHOSLA CHAITAN PHD Director Grant or award · Stock Option (right to buy) +15,000 15,000
2020-05-28 Giraudo Bryan Director Grant or award · Stock Option (right to buy) +15,000 15,000
2020-04-29 PATEL DINESH V PH D President and CEO Gift −2,000 437,990
2020-03-20 PATEL DINESH V PH D President and CEO Option exercise +10,000 $1.89 $19K 439,990
2020-03-20 PATEL DINESH V PH D President and CEO Option exercise · Stock Option (right to buy) −10,000 34,087
2020-03-12 PATEL DINESH V PH D President and CEO Option exercise +18,344 $1.16 $21K 429,990
2020-03-12 PATEL DINESH V PH D President and CEO Option exercise · Stock Option (right to buy) −18,344 0
2020-03-12 SELICK HAROLD E Director Purchase +12,000 $6.70 $80K 15,310
2020-02-28 Saks Samuel R Chief Medical Officer Grant or award · Stock Option (right to buy) +85,000 85,000
2020-02-28 PATEL DINESH V PH D President and CEO Grant or award · Stock Option (right to buy) +235,000 235,000
2020-02-28 Liu David Y Chief Scientific Officer Grant or award · Stock Option (right to buy) +70,000 70,000
2020-02-28 Kalkofen Donald A. Chief Financial Officer Grant or award · Stock Option (right to buy) +55,000 55,000
2020-02-28 Gupta Suneel Chief Development Officer Grant or award · Stock Option (right to buy) +85,000 85,000
2019-12-03 Giraudo Bryan Director Purchase +8,000 $5.70 $46K 8,000
2019-12-03 Gupta Suneel EVP Clinical Operations Purchase +30,000 $5.13 $154K 49,500
2019-12-03 Kalkofen Donald A. Chief Financial Officer Purchase +613 $5.10 $3K 613
2019-12-03 Kalkofen Donald A. Chief Financial Officer Purchase +562 $5.09 $3K 1,175
2019-12-03 PATEL DINESH V PH D President and CEO Purchase +10,000 $5.55 $56K 389,824
2019-12-03 PATEL DINESH V PH D President and CEO Purchase +20,000 $5.65 $113K 409,824
2019-11-26 PATEL DINESH V PH D President and CEO Option exercise +4,000 $1.16 $5K 379,824

Page 20 of 29 · 580 trades